Tradestie Institutional Equity Comparison Engine

BBC vs PTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BBC Overall Edge

BBC Captures Institutional Edge (2โ€“0 Pillars ยท 0โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Virtus LifeSci Biotech Clinical Trials ETF (BBC) driven by superior Momentum & Technical, Options & Structure. Fundamentally, BBC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PTH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BBC sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against PTH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BBC N/M vs PTH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner BBC
1Y +29.8% vs +17.5% ยท 52W Pos 38% vs 54%
Options & Structure Winner BBC
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (100th %ile IV)
BBC NYSE Arca
Virtus LifeSci Biotech Clinical Trials ETF
Institutional Equity
$40.85
-3.94% 1D
Market Cap N/A
1M Return +4.42%
1Y Return +29.84%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 46.0 Fund 52.0 Flow 50.0 Mom 60.0
PTH NASDAQ
Invesco Exchange-Traded Fund Trust Invesco Dorsey Wright Healthcare Momentum ETF
Institutional Equity
$55.90
-2.46% 1D
Market Cap N/A
1M Return +0.01%
1Y Return +17.52%
Forward P/E N/M
Unified AI Score
49.2 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BBC +29.84% PTH +17.52% Spread: +12.32 pp (BBC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BBC TTM Op. Margin: N/A PTH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBC vs PTH. Trailing 12-month operating profitability (BBC N/A vs PTH N/A) and valuation multiples (BBC N/M vs PTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BBC (0) vs PTH (3)
Institutional Metric BBC PTH Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 38% ($31โ€“$56) 54% ($46โ€“$64) Stronger Trend PTH
Beta / 30D Volatility Risk Regime 1.45ฮฒ ยท 50% Vol 1.22ฮฒ ยท 41% Vol Lower Realized Risk PTH
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 49.2 / 100 (HOLD) Higher Composite PTH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BBC vs PTH Buy Guide
BBC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live BBC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live PTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BBC nor PTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.